by Molsoft
Screening library of 2500+ 2D and 3D models for target identification, lead discovery, and ADMET prediction across 1200 pharmacology and toxicology targets.
Computational Drug Safety & PKPD Modeling
by Quris AI
Drug safety prediction using machine learning trained on patients-on-a-chip data.
Computational Drug Safety & PKPD Modeling
by Lhasa
Computational Drug Safety & PKPD Modelingby Lhasa
Computational Drug Safety & PKPD Modelingby Lhasa
Page not found. Unable to generate description due to missing product content.
Computational Drug Safety & PKPD Modelingby Lhasa
In silico carcinogenicity assessment using curated data, structural alerts, and adverse outcome pathways to support regulatory decision-making.
Computational Drug Safety & PKPD Modelingby Lhasa
Predict metabolic pathways and Phase I/II biotransformations to assess metabolic fate and toxicity of drug candidates and their metabolites.
Computational Drug Safety & PKPD Modelingby Lhasa
Mutagenic impurity risk assessment and degradant prediction for pharmaceutical drug development and regulatory compliance.
Computational Drug Safety & PKPD Modelingby Lhasa
Risk assessment and degradation prediction for mutagenic impurities and degradants in pharmaceutical development.
Computational Drug Safety & PKPD Modelingby Lhasa
Elemental impurity assessment for ICH Q3D, identifying impurity sources in APIs and excipients to guide control strategies.
Computational Drug Safety & PKPD Modelingby Lhasa
Adverse outcome pathway-based safety profiling for predicting human toxicity risks in drug discovery.
Computational Drug Safety & PKPD Modelingby Lhasa
Hazard and potency predictions for skin sensitisation assessment, combining in silico analysis with in chemico and in vitro data as an alternative to animal testing.
Computational Drug Safety & PKPD Modeling
by Insilico Medicine
Data-driven forecast of clinical trial probability of success for portfolio risk assessment and trial design optimization.
Computational Drug Safety & PKPD Modeling
by InSilicoTrials
Clinical trial simulation, digital twins, and synthetic patient generation for preclinical to post-approval drug development decisions.
Computational Drug Safety & PKPD Modelingby InSilicoTrials
Immunoinformatics and disease modeling for vaccine design, efficacy prediction, and in silico clinical trials.
Computational Drug Safety & PKPD Modelingby InSilicoTrials
Modeling and simulation for oncology drug efficacy, safety, and dose optimization through in silico clinical trials.
Computational Drug Safety & PKPD Modeling
by Unlearn.AI
Evidence-backed clinical trial design with AI-powered literature review, historical data exploration, and scenario simulation.
Computational Drug Safety & PKPD Modelingby Unlearn.AI
AI-generated forecasts of individual trial participant outcomes to increase statistical power, reduce sample sizes, and improve clinical trial sensitivity.
Computational Drug Safety & PKPD Modeling
by Optibrium
Phase I and II metabolite prediction using quantum mechanics and machine learning for DMPK compound optimization.
Computational Drug Safety & PKPD Modeling
by Quanthealth
Clinical trial simulation with AI to predict trial outcomes, optimize protocols, and accelerate drug development decisions.
Computational Drug Safety & PKPD Modeling